For further educational resources, please see our article on weight management and hidden causes
They should be carefully administered to patients with risks of hypovolemia (older age, cardiovascular diseases, treatment with diuretics, liver cirrhosis with circulatory dysfunction)
The patient is either receiving guideline-directed medical therapy (GDMT) for cardiovascular disease or has a documented clinical reason for not receiving it (such as a contraindication to lipid-lowering agents, antiplatelets, beta-blockers, or renin-angiotensin inhibitors) ( Documentation is required for approval) Continuation of therapy: The request is for continued treatment, and
ncbi.nlm.nih.gov/books/NBK499877/ Agarwal, A., Sengupta, P., & Durairajanayagam, D
Retatrutide offers a non-surgical alternative with reversibility, though long-term weight maintenance after discontinuation remains under study